Diamyd Medical (Germany) Probability of Future Stock Price Finishing Over 0.99
| DMN Stock | EUR 0.95 0.04 4.04% |
Diamyd |
Diamyd Medical Target Price Odds to finish over 0.99
The tendency of Diamyd Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over € 0.99 or more in 90 days |
| 0.95 | 90 days | 0.99 | about 92.17 |
Based on a normal probability distribution, the odds of Diamyd Medical to move over € 0.99 or more in 90 days from now is about 92.17 (This Diamyd Medical AB probability density function shows the probability of Diamyd Stock to fall within a particular range of prices over 90 days) . Probability of Diamyd Medical AB price to stay between its current price of € 0.95 and € 0.99 at the end of the 90-day period is under 4.
Assuming the 90 days horizon Diamyd Medical has a beta of 0.85 suggesting Diamyd Medical AB market returns are reactive to returns on the market. As the market goes up or down, Diamyd Medical is expected to follow. Additionally Diamyd Medical AB has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Diamyd Medical Price Density |
| Price |
Predictive Modules for Diamyd Medical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Diamyd Medical AB. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Diamyd Medical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Diamyd Medical is not an exception. The market had few large corrections towards the Diamyd Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Diamyd Medical AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Diamyd Medical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.72 | |
β | Beta against Dow Jones | 0.85 | |
σ | Overall volatility | 0.12 | |
Ir | Information ratio | -0.22 |
Diamyd Medical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Diamyd Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Diamyd Medical AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Diamyd Medical AB generated a negative expected return over the last 90 days | |
| Diamyd Medical AB has some characteristics of a very speculative penny stock | |
| Diamyd Medical AB has high historical volatility and very poor performance | |
| Diamyd Medical AB has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 454 K. Net Loss for the year was (103.52 M) with loss before overhead, payroll, taxes, and interest of (3.95 M). | |
| Diamyd Medical generates negative cash flow from operations | |
| About 35.0% of the company shares are held by company insiders |
Diamyd Medical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Diamyd Stock often depends not only on the future outlook of the current and potential Diamyd Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Diamyd Medical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 76.9 M |
Diamyd Medical Technical Analysis
Diamyd Medical's future price can be derived by breaking down and analyzing its technical indicators over time. Diamyd Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Diamyd Medical AB. In general, you should focus on analyzing Diamyd Stock price patterns and their correlations with different microeconomic environments and drivers.
Diamyd Medical Predictive Forecast Models
Diamyd Medical's time-series forecasting models is one of many Diamyd Medical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Diamyd Medical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Diamyd Medical AB
Checking the ongoing alerts about Diamyd Medical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Diamyd Medical AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Diamyd Medical AB generated a negative expected return over the last 90 days | |
| Diamyd Medical AB has some characteristics of a very speculative penny stock | |
| Diamyd Medical AB has high historical volatility and very poor performance | |
| Diamyd Medical AB has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 454 K. Net Loss for the year was (103.52 M) with loss before overhead, payroll, taxes, and interest of (3.95 M). | |
| Diamyd Medical generates negative cash flow from operations | |
| About 35.0% of the company shares are held by company insiders |
Other Information on Investing in Diamyd Stock
Diamyd Medical financial ratios help investors to determine whether Diamyd Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Diamyd with respect to the benefits of owning Diamyd Medical security.